cyclohexanol has been researched along with tolcapone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clarke, G; Clarke, N; Cryan, JF; Desbonnet, L; Dinan, TG; Gogos, JA; Karayiorgou, M; O'Leary, C; O'Tuathaigh, CM; Petit, E; Tighe, O; Waddington, JL; Walsh, J | 1 |
1 other study(ies) available for cyclohexanol and tolcapone
Article | Year |
---|---|
Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.
Topics: Alleles; Animals; Anxiety; Benzophenones; Benzoxazines; Biogenic Monoamines; Cannabinoid Receptor Agonists; Cannabinoids; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Chromatography, High Pressure Liquid; Cyclohexanols; Enzyme Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Nitrophenols; Pain Measurement; Phenotype; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Social Behavior; Swimming; Tolcapone | 2012 |